PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Democratizing plant research: A new cost-effective solution for advanced phenotyping

2024-06-05
(Press-News.org) Phenotyping, which involves assessing observable plant characteristics, is crucial for understanding plant development and response to environmental stresses. Traditional methods are often cumbersome, costly, and destructive, limiting research scope and scale. A new system of affordable, mobile, and high-throughput phenotyping tools is making the technology accessible to a wider range of users.

The "all-in-one" solution, developed by a team at the Boyce Thompson Institute (BTI), includes low-cost hardware designs, data processing pipelines, and a user-friendly data analysis platform. BTI’s system captures data without harming plants, allowing continuous monitoring of plant growth and providing a nuanced understanding of plant responses over time. The integration of simple hardware with sophisticated computational pipelines creates an effective high-throughput phenotyping solution.

“By lowering the cost and technical barriers of advanced plant phenotyping, our work empowers researchers worldwide to conduct affordable, data-driven studies,” said Magda Julkowska, an assistant professor at BTI and co-lead author of the study. “This could accelerate the breeding of more resilient and productive crops, enhancing food security in a sustainable way.”

Using their new phenotyping toolset, the research team analyzed the drought resilience of cowpeas, a staple food crop for millions in arid regions. They identified several genetic loci linked to drought response, paving the way for breeding more resilient varieties. These results and the details of their innovative platform were recently published in Plant Physiology.

“This technology could help transform regions where water scarcity threatens food security by enabling localized, cost-effective research into crop performance under stress conditions,” noted Li’ang Yu, a postdoctoral scientist at BTI and co-first author of the study. “The system's adaptability means it can be used for various species, from staple crops to less common plants.”

One of the system's standout features is its integration with computational pipelines designed for ease of use. Hayley Sussman, a BTI scientist and co-first author of the study, explains, “The RaspiPheno App we developed streamlines data analysis, offering an interactive platform for processing and visualizing phenotypic data. This shortens  the learning curve and lets researchers focus on biological insights rather than technical hurdles​​.”

Looking ahead, the team is excited for others to adopt and build upon this system. All hardware designs, software, and detailed protocols have been made publicly available. "By making these tools open-access, we hope to enable novel discoveries and collaborations that can help tackle some of the major challenges facing agriculture today," said Andrew Nelson, an assistant professor at BTI and co-lead author of the study.

The team’s work is a compelling example of how improving phenotyping technologies can accelerate plant biology research and translation. As more scientists leverage these tools, we can expect faster progress in understanding key traits and developing more resilient, productive crop varieties for the future.

About the Boyce Thompson Institute (BTI)
Founded in 1924 and located in Ithaca, New York, BTI is at the forefront of plant science research. Our mission is to advance, communicate, and leverage pioneering discoveries in plant sciences to develop sustainable and resilient agriculture, improve food security, protect the environment, and enhance human health. As an independent nonprofit research institute affiliated with Cornell University, we are committed to inspiring and training the next generation of scientific leaders. Learn more at BTIscience.org.

END


ELSE PRESS RELEASES FROM THIS DATE:

Multiple randomized trials prove more stroke patients can benefit from thrombectomy

2024-06-05
FOR IMMEDIATE RELEASE: June 5, 2024 CONTACT: Faith James fjames@vancomm.com or 202-248-5450   Multiple Randomized Trials Prove More Stroke Patients Can Benefit from Thrombectomy Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke   FAIRFAX, Va. — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion (BAO), a deadly type ...

Researchers led by UMass Amherst solve 2,000-year-old mystery of the shipworm

Researchers led by UMass Amherst solve 2,000-year-old mystery of the shipworm
2024-06-05
June 5, 2024   Researchers Led by UMass Amherst Solve 2,000-Year-Old Mystery of the Shipworm Secret of the world’s most destructive and intriguing mollusk has implications for everything from climate change to human health   AMHERST, Mass. – They bedeviled ancient Greek navies, helped shipwreck Christopher Columbus, aided in the sinking of the Spanish Armada and caused the wharves in San Francisco Bay to collapse into the sea, but until now, scientists have been unable to pinpoint exactly ...

Immunotherapy before surgery very successful in treating colorectal cancer

Immunotherapy before surgery very successful in treating colorectal cancer
2024-06-05
A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two third of patients, there were no longer any live tumor cells at the time of surgery. The patients’ immune system had cleaned up the cancer cells. These groundbreaking discoveries were made as part of the NICHE-2 trial at the Netherlands Cancer Institute and have been published in the New England Journal of Medicine. Patients with colon cancer with ...

Encouraging Phase 1 data for glioblastoma treatment reported by UAB researchers at ASCO

Encouraging Phase 1 data for glioblastoma treatment reported by UAB researchers at ASCO
2024-06-05
BIRMINGHAM, Ala. – Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months with concomitant temozolomide chemotherapy. The median follow-up was 11.7 months. This survival data along with radiographic improvements are indicative of positive treatment effects, which highlights the potential of IN8bio’s genetically modified, chemotherapy-resistant gamma-delta T cells ...

YALE NEWS: Early life experiences linked to racial disparities in cognition

2024-06-05
New Haven, Conn. — Negative early life experiences, such as attending segregated schools, contribute significantly to cognitive decline and cognition disparities between older Black and white Americans, according to a new study led by researchers at the Yale School of Public Health. The study, published in JAMA Internal Medicine, is the first to look at the impact of school segregation upon later life cognition using a large representative sample of the U.S. population, said lead author Xi Chen, associate professor of public ...

Nationally known pediatric infectious disease researcher named vice chancellor for research at the University of Tennessee Health Science Center

2024-06-05
After an extensive national search, Jessica Snowden, MD, MS, FAAP, MHPTT, a nationally recognized pediatric infectious disease specialist and researcher, has been named the new vice chancellor for Research at the University of Tennessee Health Science Center, effective September 1. She will also serve as a professor in the College of Medicine in the Department of Pediatrics. Currently the vice dean for Research and chief of Pediatric Infectious Diseases at the University of Arkansas for Medical Sciences (UAMS), Dr. Snowden is known as a dedicated mentor and a leader in integrating clinical, research, and academic efforts to advance the understanding ...

Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy

Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy
2024-06-05
“The results provide novel preclinical data that demonstrate synergism between HDACi- and PARPi-mediated inhibition of DNA repair and decitabine in pancreatic cancer [...]” BUFFALO, NY- June 5, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 3, 2024, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.” Histone deacetylase inhibitors (HDACi) can modulate the acetylation status of proteins, influencing the genomic instability exhibited by cancer cells. Poly (ADP ribose) ...

UBC-developed oral insulin drops offer relief for diabetes patients

UBC-developed oral insulin drops offer relief for diabetes patients
2024-06-05
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily. Researchers at the Li Lab have developed oral insulin drops that when placed under the tongue are quickly and efficiently absorbed by the body, potentially replacing the need for insulin injections. The drops contain a mixture of insulin and a unique cell-penetrating peptide (CPP) developed ...

Could taking certain drugs reduce risk of ruptured brain aneurysm?

2024-06-05
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 5, 2024 MINNEAPOLIS – A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The results do not prove that these drugs reduce the risk of this type of aneurysm; they only show an association. “We urgently need new ways to prevent this type of stroke, which occurs at younger ages and with a higher death rate than other types of stroke,” said study author Jos Peter Kanning, ...

Fellowships will advance reporters’ coverage of aging in America

2024-06-05
The Gerontological Society of America (GSA) has received renewed grant support to welcome a 15th class of reporters for the Journalists in Aging Fellows Program. The 2024 funders to date include Silver Century Foundation, The John A. Hartford Foundation, and National Institute for Health Care Management Foundation (NIHCM). Since its founding in 2010, this program has been responsible for more than 800 news stories produced by 231 alumni. It has two goals: to educate journalists about issues in aging, better allowing them to spread a new awareness to general-audience, ethnic, and other minority populations; and to disseminate information about new scientific findings, ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Democratizing plant research: A new cost-effective solution for advanced phenotyping